Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2019
Price : $35 *
At a glance
- Drugs Leuprorelin (Primary) ; Palifermin (Primary) ; Cyclophosphamide; Degarelix; Thiotepa
- Indications Immunosuppression
- Focus Therapeutic Use
- 17 Oct 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 17 Oct 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 31 Aug 2018 Biomarkers information updated